Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. - Wikidata - wikimedia - TriplyDB

Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.

Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.

http://www.wikidata.org/entity/Q46620565

about

Interventions to prevent steroid-induced osteoporosis and osteoporotic fractures in Duchenne muscular dystrophy Once-yearly zoledronic acid in hip fracture prevention Position Statement: Drug Holiday in Osteoporosis Treatment with Bisphosphonates in South Korea Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research Bisphosphonate therapy in pediatric patients Postmenopausal osteoporosis treatment with antiresorptives: effects of discontinuation or long-term continuation on bone turnover and fracture risk--a perspective Bisphosphonate drug holiday: choosing appropriate candidates Atypical femoral fracture in a beta-thalassemia major patient with previous bisphosphonate use: case report and a review of the literature A novel bisphosphonate inhibitor of squalene synthase combined with a statin or a nitrogenous bisphosphonate in vitro Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis?Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity.Bisphosphonates and bone quality.Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate.Smart, programmable and responsive injectable hydrogels for controlled release of cargo osteoporosis drugs.Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis.Polycaprolactone-coated 3D printed tricalcium phosphate scaffolds for bone tissue engineering: in vitro alendronate release behavior and local delivery effect on in vivo osteogenesis A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum.A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years.Improved small molecule drug release from in situ forming poly(lactic-co-glycolic acid) scaffolds incorporating poly(β-amino ester) and hydroxyapatite microparticles.Efficacy of ibandronate: a long term confirmation.Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis Natural-abundance 43Ca solid-state NMR spectroscopy of bone.Molecular mechanisms of crystallization impacting calcium phosphate cements.Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment Once-monthly risedronate for postmenopausal osteoporosis Peri-implant and systemic effects of high-/low-affinity bisphosphonate-hydroxyapatite composite coatings in a rabbit model with peri-implant high bone turnover.pH-responsive NIR enhanced drug release from gold nanocages possesses high potency against cancer cells.Increased bone mineral density with monthly intravenous ibandronate contributes to fracture risk reduction in patients with primary osteoporosis: three-year analysis of the MOVER study.Adjuvant therapy with zoledronic acid in patients with breast cancer: a systematic review and meta-analysis.Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosis Calcium orthophosphates: crystallization and dissolution.Role of zoledronic acid in the prevention and treatment of osteoporosis.Neridronic acid for the treatment of bone metabolic diseases.The Effect of Osteoporosis Treatments on Fatigue Properties of Cortical Bone Tissue.

P2860

Q24198280-B2A7B442-17E8-4C65-8FF1-290CF5061C8F Q24657667-959CDFCF-17A0-401E-8ED7-1432123E6A0D Q26771713-BF862ED5-65A5-4908-B52E-9D47212F6992 Q26782621-167F093E-A67C-4E63-B93E-ED62E6F1EB87 Q26830702-88F35111-EE72-4356-968D-3EC759DC875A Q26864207-308DD9DC-3E13-413A-AD28-458F7AB383C9 Q27004682-08E4A890-7187-4280-B108-5F2D289450F2 Q28071432-4AE257D5-08D7-4DDB-9356-246528692B79 Q28247578-B3441567-4078-4EB4-8DEB-1F0C5BE85D6A Q30978614-612C076B-846C-456A-810F-00902C071961 Q33557256-6CFD9257-5710-4029-B4A4-1A45B197749B Q33587793-FFAC9D1C-0EED-4C11-AE07-0FCA8F7B4DB4 Q33665130-E552D0E4-DB3C-4F16-B537-1A0075BBA17C Q33683219-2D897329-35D1-4575-AFC9-CEB0074CDD4D Q33742858-4E092F5F-BA32-4A3E-BE60-461B592325E0 Q33841863-1C96BC27-5C7C-4445-AA4D-E21D7C7F37B3 Q33881531-0EE3C46A-4B93-4B81-A9C8-620767D8E3E2 Q33886852-C925F15D-577C-4027-81C6-961519E7349C Q33893639-B07E0CDE-8ADA-4201-AA08-26EB2A61FC48 Q33916132-749879E4-37B2-4F4D-B998-959D3C1AB25D Q33921570-F7D67BB7-EF79-49D5-89D5-DDE2FC7D853C Q33933594-F8685A99-D7E4-4A51-901D-EC3891C3C3F6 Q33965657-0E029D18-FF43-48A3-A5EA-C6CDB73D5A90 Q34009569-9BF969DC-9D90-45EC-954A-CBF6F6C8BFA5 Q34018048-18F5792A-58E0-46DC-973C-544511459068 Q34042003-F892C1E2-80B5-458A-AB74-6BB571907C8A Q34073248-CBC6408C-A7A1-4B00-8D87-CBCD00D91BAF Q34150056-2DE209E9-F8E8-44BA-8736-AB8D4A3DDF35 Q34182079-7B702320-F363-40AB-A614-62D1BC563A03 Q34272000-611B1F13-9B61-4A57-A9C7-5BD78E4EE9F8 Q34299982-360CB9C1-5AA8-4FB2-A2F3-1A838B199CD3 Q34317633-F6ABBE20-CC39-45F2-980A-D8D2337D34B5 Q34553500-52E065DA-A796-4B2D-BB63-4F036BE2844E Q34583705-7DA33A2F-8B91-463E-8A11-D53B208FEF69 Q34658660-BCF1FBAD-C1A1-4646-A546-A5ABF2988A50 Q34758140-0AF14FEC-7152-4AD8-AD6C-B104B1776E68 Q34836666-D9091DB8-57D8-4621-AD23-F0011AF278BA Q34984177-039A117F-28FA-484C-B72A-5E94C4A35355 Q35003623-4DDE4DAC-BE28-4A3D-A7BB-B6EB37B784E6 Q35012189-D483B89E-538E-46C9-84DB-C3A5B5E77A73

P2860

Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.

http://www.wikidata.org/entity/Q46620565

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Novel insights into actions of ...... eractions with hydroxyapatite.

@en

Novel insights into actions of ...... eractions with hydroxyapatite.

@nl

type

label

Novel insights into actions of ...... eractions with hydroxyapatite.

@en

Novel insights into actions of ...... eractions with hydroxyapatite.

@nl

prefLabel

Novel insights into actions of ...... eractions with hydroxyapatite.

@en

Novel insights into actions of ...... eractions with hydroxyapatite.

@nl

P1433

Q46620565-ADF2E827-E18C-4707-940A-0FDC7CCB3876

P1476

Q46620565-254FBF88-6D85-4120-A8CE-B4C7494792F6

P2093

Q46620565-0B6E42A6-E05F-4566-A8B8-3665CC93B4AE

Q46620565-53EFDDA2-8544-472B-A26A-9F966D5AB5B2

Q46620565-55C11966-2A88-4D79-875D-A57740FEC55C

Q46620565-8C82F6C1-BA03-4A2C-A882-58350F48DA50

Q46620565-CDCB0F5E-32EE-48FE-B6F1-564963548A31

Q46620565-DFEEC19B-5AD4-4000-9F0C-F19C9F1A65D7

Q46620565-E2FA2528-36DF-4C58-BFC8-EDFBB5AEB6B1

Q46620565-F13310F8-FC63-4BB9-814C-901BEE2CF992

Q46620565-F7B19C12-54EC-4F4A-96E5-9C05E06126E5

P304

Q46620565-DC47A669-D71C-43EA-9D62-827AB0E4E37A

P31

Q46620565-0737AA38-2014-4AC2-9F6F-1CD4A0475335

P356

Q46620565-4F11799A-9F4B-4765-BF88-E7B5EC5C84AD

P433

Q46620565-486D740D-0F81-4221-BDE5-AF04C1CEC248

P478

Q46620565-08BC56DA-D68B-4569-B2F5-1AE5490FCE72

P577

Q46620565-C10DBB88-20F3-42E3-B91A-414FF44A3516

P5875

Q46620565-ABE03D3E-6D40-4672-AB89-5BB273072639

P698

Q46620565-5A3F13A8-AA96-4DF8-9E98-9263C7197928

P356

J.BONE.2005.05.003

P1433

P1476

Novel insights into actions of ...... eractions with hydroxyapatite.

@en

P2093

Ebetino FH

http://www.w3.org/2001/XMLSchema#string

Gulde S

http://www.w3.org/2001/XMLSchema#string

Henneman Z

http://www.w3.org/2001/XMLSchema#string

Mangood A

http://www.w3.org/2001/XMLSchema#string

Nancollas GH

http://www.w3.org/2001/XMLSchema#string

Phipps RJ

http://www.w3.org/2001/XMLSchema#string

Russell RG

http://www.w3.org/2001/XMLSchema#string

Tang R

http://www.w3.org/2001/XMLSchema#string

Wu W

http://www.w3.org/2001/XMLSchema#string

P304

617-627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BONE.2005.05.003

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

200016182

http://www.w3.org/2001/XMLSchema#string

P698

16046206

http://www.w3.org/2001/XMLSchema#string